NSS in Schizophrenia research findings and clinical relevance

Psychiatric Annals

Volumn 33, Issue 3, 2003, Pages 157-166

  Candela, Steven F ^a,b   Manschreck, Theo C ^b,c  

^a HARVARD UNIVERSITY   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c Laboratory for Clinical and Experimental Psychopathology   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ATYPICAL ANTIPSYCHOTIC AGENT; HALOPERIDOL; NEUROLEPTIC AGENT;

BRAIN REGION; CHRONIC DISEASE; CLINICAL FEATURE; COGNITIVE DEFECT; DEMOGRAPHY; DISEASE COURSE; DISEASE DURATION; DRUG RESPONSE; EDUCATION; ETHNOLOGY; HIGH RISK PATIENT; HUMAN; MEASUREMENT; MENTAL PATIENT; METHODOLOGY; MOTOR ACTIVITY; MOTOR COORDINATION; MOTOR SYSTEM; NERVOUS SYSTEM FUNCTION; NEUROLOGIC DISEASE; ONSET AGE; PATHOGENESIS; PATTERN RECOGNITION; POPULATION RESEARCH; PREVALENCE; RATING SCALE; RELIABILITY; REVIEW; RISK ASSESSMENT; SAMPLE; SCHIZOPHRENIA; SENSITIVITY ANALYSIS; SENSORY SYSTEM; SEX DIFFERENCE; SYMPTOM; TASK PERFORMANCE;

EID: 2042541387     PISSN: 00485713     EISSN: None     Source Type: Journal    
DOI: 10.3928/0048-5713-20030301-05     Document Type: Review

References (81)

1. Bombin I, Arango C, Buchanan RW. Assessment of neurological soft signs in schizophrenia. Psychiatric Annals. 2003;33:170-176.
2. Heinrichs DW, Buchanan RW. Significance and meaning of neurological signs in schizophrenia. Am J Psychiatry. 1988;145:11-18.
3. Luria AR. Higher Cortical Functions in Man. 2nd ed. New York, NY: Basic Books Inc; 1966.
4. Woods BT. Utility of neurological soft and hard signs in psychiatric research. Psychiatric Annals. 2003;33:181-189.
5. Woods BT, Kinney DK, Yurgelun-Todd D Neurologic abnormalities in schizophrenic patients and their families, I: comparison of schizophrenic, bipolar, and substance abuse patients and normal controls. Arch Gen Psychiatry. 1986;43:657-663.
6. Woods BT, Kinney DK, Yurgelun-Todd DA. Neurological "hard" signs and family history of psychosis in schizophrenia. Biol Psychiatry. 1991;30:806-816.
7. Kinney DK, Yurgelun-Todd DA, Woods BT. Neurological hard signs in schizophrenia and major mood disorders. J Nerv Ment Dis. 1993;181:202-204.
8. Griffiths TD, Sigmundson T, Rowe D, Murray RM. Neurological abnormalities in familial and sporadic schizophrenia. Brain. 1998;121:191-203.
9. Sanders RD, Keshavan MS. The neurologic examination in adult psychiatry: from soft signs to hard science. J Neuropsychiatry Clin Neurosci. 1998;10:395-404.
10. Kreb, M, Gut-Fayand A, Bourdel M, Dischamp J, Olie J. Validation and factorial structure of a standardized neurological examination assessing neurological soft signs in schizophrenia. Schizophr Res. 2000;45:245-260.
11. Chen EYH, Shapleske J, Luque R, et al. The Cambridge Neurological Inventory: a clinical instrument for assessment of soft neurological signs in psychiatric patients. Psychiatry Res. 1995;56:183-204.
12. Schröder J, Niethammer R, Geider F, et al. Neurological soft signs in schizophrenia. Schizophr Res. 1992;6:25-30.
13. Mohr F, Hubmann W, Cohen R, et al. Neurological soft signs in schizophrenia: assessment and correlates. Eur Arch Psychiatry Clin Neurosci. 1996;246:240-248.
14. Smith RC, Kadewari RP, Rosenberger JR, Bhattacharya A. Nonresponding schizophrenia: differentiation by neurological soft signs and neuropsychological tests. Schizophr Bull. 1999;25:813-825.
15. Sanders RD, Forman SD, Pierri JN, et al. Inter-rater reliability of the neurological examination in schizophrenia. Schizophr Res. 1998;29:287-292.
16. Buchanan RW, Koeppl P, Breier A. Stability of neurological signs with clozapine treatment. Biol Psychiatry. 1994;36:198-200.
17. Flashman LA, Flaum M, Gupta S, Andreasen NC. Soft signs and neuropsychological performance in schizophrenia. Am J Psychiatry. 1996;153:526-532.
18. Boks MPM, Russo S, Knegtering R, van der Bosch RJ. The specificity of neurological signs in schizophrenia: a review. Schizophr Res. 2000;43:109-116.
19. Rochford MD, Detre MD, Tucker GJ, Harrow M. Neuropsychological impairments in functional psychiatric diseases. Arch Gen Psychiatry. 1970;22:114-119.
20. Schaffer D. Soft neurological signs and later psychiatric disorder: a review. J Child Psychol Psychiatry. 1978;19:63-65.
21. Manschreck TC, Ames D. Neurologic features and psychopathology in schizophrenic disorders. Biol Psychiatry. 1984;19:703-719.
22. Tucker GJ, Campion EW, Silberfarb PM. Sensorimotor functions and cognitive disturbance in psychiatric patients. Am J Psychiatry. 1975;132:17-21.
23. Marcus J, Hans SL, Lewow E, Wilkinson L, Burack CM. Neurologic findings in high-risk children: childhood assessment and 5-year follow-up. Schizophr Bull. 1985;11:85-100.
24. Obiols JE, Serrano F, Caparros B, Subira S, Barranted N. Neurological soft signs in adolescents with poor performance on the continuous performance test: markers of liability for schizophrenia spectrum disorders? Psychiatry Res. 1999;86:217-228.
25. Walker EF, Savoie T, Davis D. Neuromotor precursors of schizophrenia. Schizophr Bull. 1994;20:441-451.
26. Chen YLR, Chen YHE, Mak FL. Soft neurological signs in schizophrenic patients and their nonpsychotic siblings. J Nerv Ment Dis. 2000;188:84-89.
27. Egan MF, Hyde TM, Bonomo JB, et al. Relative risk of neurological signs in siblings of patients with schizophrenia. Am J Psychiatry. 2001;158:1827-1834.
28. Ismail B, Cantor-Graae E, McNeil TF. Neurological abnormalities in schizophrenic patients and their siblings. Am J Psychiatry. 1998;155:84-89.
29. Buchanan RW, Heinrichs DW. The Neurological Evaluation Scale (NES): a structured instrument for the assessment of neurological signs in schizophrenia. Psychiatry Res. 1989;27:335-350.
30. Maher BA, Manschreck TC. Lateralization, memory, and language in schizophrenia: some facts and an artifact. In: Lenzenweger MF, Dworkin RH, eds. Origin and Development of Schizophrenia: Advances in Experimental Psychopathology. Washington, DC: American Psychological Association Press; 1998:211-233.
31. Wolff A, O'Driscoll GA. Motor deficits and schizophrenia: the evidence from neurolepticnaive patients and populations at risk. J Psychiatry Neurosci. 1999;24:304-314.
32. Wong AHS, Voruganti LNP, Heslegrave RJ, Awad AG. Neurocognitive deficits and neurological signs in schizophrenia. Schizophr Res. 1997;23:139-146.
33. Gupta S, Andreasen NC, Arndt S, et al. Neurological soft signs in neuroleptic-naive and neuroleptic-treated schizophrenic patients and in normal comparison subjects. Am J Psychiatry. 1995;152:191-196.
34. Sanders RD, Keshavan MS, Schooler NR. Neurological examination abnormalities in neuroleptic-naive patients with first-break schizophrenia: preliminary results. Am J Psychiatry. 1994;151:1231-1233.
35. Browne S, Clarke M, Gervin M, et al. Determinants of neurological dysfunction in first episode schizophrenia. Psychol Med. 2000;30:1433-1441.
36. Rubin P, Vorstup S, Hemmingsen R, et al. Neurological abnormalities in patients with schizophrenia or schizophreniform disorder at first admission to hospital: correlations with computerized tomography and regional blood flow findings. Acta Psychiatr Scand. 1994;90:385-390.
37. Scottish Schizophrenia Research Group. The Scottish first episode schizophrenia study, I: patient identification and categorisation. Br J Psychiatry. 1988;150:331-333.
38. Rossi A, De Cataldo S, Di Michele V, et al. Neurological soft signs in schizophrenia. Br J Psychiatry. 1990;157:735-739.
39. Bartko G, Zador G, Horvath S, Herczeg I. Neurological soft signs in chronic schizophrenic patients: clinical correlates. Biol Psychiatry. 1988;24:458-460.
40. Braun CMJ, Lapierre D, Hodgins S, Toupin J, Leveille S, Constantineau C. Neurologie soft signs in schizophrenia: are they related to negative or positive symptoms, neuropsychological performance, and violence? Arch Clin Neuropsychol. 1995;10:489-509.
41. Cuesta MJ, Peralta V, de Leon J. Neurological frontal signs and neuropsychological deficits in schizophrenic patients. Schizophr Res. 1996;20:15-20.
42. Lane A, Colgan K, Moynihan F, et al. Schizophrenia and neurological soft signs: gender difference in clinical correlates and antecedent factors. Psychiatry Res. 1996;64:105-114.
43. King DJ, Wilson A, Cooper SJ, Waddington JL. The clinical correlates of neurological soft signs in chronic schizophrenia. Br J Psychiatry. 1991;158:770-775.
44. Schröder J. Neurological soft signs and neuroleptic side effects in schizophrenia. Psychiatric Annals. 2003;33:214-220.
45. Merriam AE, Kay SR, Opler LA, Kushner SF, van Praag HM. Neurological signs and the positive-negative dimension in schizophrenia. Biol Psychiatry. 1990;28:181-192.
46. Sauer H, Hornstein C, Richter P, Mortimer A, Hirsch SR. Symptom dimensions in old-age schizophrenics: relationships to neuropsychological and motor abnormalities. Schizophr Res. 1999;39:31-38.
47. Smith RC, Kadewari RP. Neurological soft signs and response to risperidone in chronic schizophrenia. Biol Psychiatry. 1996;40:1056-1059.
48. Buchanan RW, Kirkpatrick B, Heinrichs DW, Carpenter WT. Clinical correlates of the deficit syndrome of schizophrenia. Am J Psychiatry. 1990;147:290-294.
49. Arango C, Kirkpatrick B, Buchanan RW. Neurological signs and the heterogeneity of schizophrenia. Am J Psychiatry. 2000;157:560-565.
50. Doody GA, Johnstone EC, Sanderson TL, Cunningham-Owens DG, Muir WJ. "Pfropfschizophrenie" revisited: schizophrenia in people with mild learning disability. Br J Psychiatry. 1999;173:145-153.
51. Galderisi S, Bucci P, Mucci A, D'Amato AC, Conforti R, Maj M. "Simple schizophrenia": a controlled MRI and clinical/ neuropsychological study. Psychiatry Res. 1999;91:175-184.
52. Schröder J, Buchsbaum MS, Siegel BV, Geider FJ, Niethammer R. Structural and functional correlates of subsyndromes in chronic schizophrenia. Psychopathology. 1995;28, 38-45.
53. Schröder J, Tittel A, Stockert A, Karr M. Memory deficits in subsyndromes of chronic schizophrenia. Schizophr Res. 1996;21:19-26.
54. Ceskova E, Krybcak P, Hrobar P, Lorenc M, Prochazkova H, Spacek J. The changes of biological markers and treatment efficacy in schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry. 2001;25:323-335.
55. Schröder J, Silvestri S, Bubeck B, et al. D-sub-2 dopamine receptor up-regulation, treatment response, neurological soft signs, and extrapyramidal side effects in schizophrenia: a follow-up study with -sup-1-sup-2-sup-3I- iodobenzamide single photon emission computed tomography in the drug-naive state and after neuroleptic treatment. Biol Psychiatry. 1998;43:660-665
56. Vaid G, Smith RC, Rosenberger J, Alter I. Neurological and neuropsychological tests in schizophrenia. Biol Psychiatry. 1993;33(suppl 6A):92.
57. Convit A, Volavka J, Czobor P, de Asis J, Evangelista C. Effect of subtle neurological dysfunction on response to haloperidol treatment in schizophrenia. Am J Psychiatry. 1994;151:49-56.
58. Sanders RD, Keshavan MS, Goldstein G. Clinical utility of the neurological examination in psychoses. Psychiatric Annals. 2003;33:195-200.
59. Adams JJ, Meloy JR, Moritz MS. Neuropsychological deficits and violent behavior in incarcerated schizophrenics. J Nerv Ment Dis. 1990;178:253-256.
60. Krakowski MI, Convit A, Jaeger J, Lin S, Volavka J. Neurological impairment in violent schizophrenic inpatients. Am J Psychiatry. 1989;146:849-853.
61. Gupta S, Rajaprabhakaran R, Arndt S, Raum M, Andreasen NC. Premorbid adjustment as a predictor of phenomenological and neurobiological indices in schizophrenia. Schizophr Res. 1995;16:189-197.
62. Malla AK, Norman RMG, Aguilar O, Cortese L. Relationship between neurological "soft signs" and syndromes of schizophrenia. Acta Psychiatr Scand. 1997;96:274-280.
63. Bartko G, Frecska E, Zador G, Harczeg I. Neurological features, cognitive impairment and neuroleptic response in schizophrenic patients. Schizophr Res. 1989;2:311-313.
64. Martin P, Tewesmeiser M, Albers M, Shmid GB, Scharfetter C. Towards an understanding of sensory soft signs of schizophrenia. Psychopathology. 1995;28:281-284.
65. Sanders RD, Keshavan MS, Forman SD, et al. Factor structure of neurologic examination abnormalities in unmedicated schizophrenia. Psychiatry Res. 2000;95:237-243.
66. Chen EYH, Lam LCW, Chen RYL, Nguyen DGH. Neurological signs, age, and illness duration in schizophrenia. J Nerv Ment Dis. 1996;184:339-345.
67. Pulver AE, Buchanan RW, Thompson BW, McGrath J, Wolyniec PS. Neurologic soft signs in an epidemiological sample of first admission psychotic patients: a preliminary analysis. In: Schulz SC, Tamminga CA, eds. Schizophrenia: Scientific Progress. New York, NY: Oxford University Press; 1989:78-82.
68. Chen EYH, Chan RCK. Clinical, demographic, and ethnic correlates of neurological soft signs in schizophrenia. Psychiatric Annals. 2003;33:202-210.
69. Fish B, Marcus J, Hans SL. Infants at risk for schizophrenia: sequelae of a genetic neurointegrative defect. Arch Gen Psychiatry. 1992;49:221-235.
70. Sachdev P, Brodaty H, Rose N, Cathcart S. Schizophrenia with onset after age 50 years, II: neurological, neuropsychological, and MRI investigation. Br J Psychiatry. 1999;175:416-421.
71. Bender L. Childhood schizophrenia: clinical study of 100 schizophrenic children. Am J Orthopsychiatry. 1947;17:40.
72. Pollack M, Goldfarb W. The face-hand test in schizophrenic children. Archives of Neurology and Psychiatry. 1957;77:635-342.
73. Karp BI, Garvey M, Jacobsen LK, et al. Abnormal neurologic maturation in adolescents with early-onset schizophrenia. Am J Psychiatry. 2001;158:118-122.
74. Green MF. What are the functional consequences of neurocognitive deficits in schizophrenia? Am J Psychiatry. 1996;153:321-330.
75. Manschreck TC, Redmond DA, Candela SF, Maher BA. Effects of clozapine on psychiatric symptoms, cognition, and functional outcome in schizophrenia. J Neuropsychiatry Clin Neurosci. 1999;11:481-489.
76. Meltzer HY, Thompson PA, Lee MA, Ranjan R. Neuropsychologic deficits in schizophrenia: relation to social function and effect of antipsychotic drug treatment. Neuropsychopharmacology. 1996;14(suppl 3):27s-33s.
77. Liddle, PF. Schizophrenic syndromes, cognitive performance and neurological dysfunction. Psychol Med. 1987;17:49-57.
78. Arango C, Bartko JJ, Gold JM, Buchanan RW. Prediction of neuropsychological performance by neurological signs in schizophrenia. Am J Psychiatry. 1999;156:1349-1357.
79. Chen EYH, Lam LCW, Chen RYL, Nguyen DGH, Kwok CL, Au JWY. Neurologic signs and sustained attention impairment in schizophrenia. Eur Arch Psychiatry Clin Neurosci. 2001;251:1-5.
80. Flyckt L, Sydow O, Bjerkenstedt L, Edman G, Rydin E, Wiesel FA. Neurological signs and psychomotor performance in patients with schizophrenia, their relatives and healthy controls. Psychiatry Res. 1999;86:113-129.
81. Meehl PE. Toward an integrated theory of schizotaxia, schizotypy, and schizophrenia. J Personal Disord. 1990;4:1-99.